Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Zimmermann

Showing results (381-390 of 388) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 388 results.
Protoplasma|January 8, 2008
Foliar water supply of tall trees: evidence for mucilage-facilitated moisture uptake from the atmosphere and the impact on pressure bomb measurementsD Zimmermann, M Westhoff, G Zimmermann, et al.
Biomaterials|May 26, 2005
Real-time 3-D dark-field microscopy for the validation of the cross-linking process of alginate microcapsulesR Wolf, D Zimmermann, M Weber, et al.
Oncogene|August 30, 2001
No evidence of somatic FGFR3 mutation in various types of carcinomaM Karoui, H Hofmann-Radvanyi, U Zimmermann, et al.
British Journal of Cancer|March 18, 2004
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastasesM Karoui, C Tresallet, C Julie, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 29, 2009
Pharmacotherapy guidelines for the aged by family doctors for the use of family doctors - Part D Basic conditions supporting drug treatment. Part E Guidelines group, disclaimer, internet addressesGuidelines Group Hesse Pharmacotherapy Guidelines by Family Doctors for Family Doctors, F W Bergert, D Conrad, et al.
Journal of Materials Science. Materials in Medicine|June 2, 2005
Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantationH Zimmermann, D Zimmermann, R Reuss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trialL Bergmann, L Albiges, M Ahrens, et al.
Applied Biochemistry and Biotechnology|November 16, 2013
Patents and literatureM Kit, M J Narasimhan, J A Anderson, et al.
Pageof 39

Showing results (381-390 of 388) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 388 results.
Protoplasma|January 8, 2008
Foliar water supply of tall trees: evidence for mucilage-facilitated moisture uptake from the atmosphere and the impact on pressure bomb measurementsD Zimmermann, M Westhoff, G Zimmermann, et al.
Biomaterials|May 26, 2005
Real-time 3-D dark-field microscopy for the validation of the cross-linking process of alginate microcapsulesR Wolf, D Zimmermann, M Weber, et al.
Oncogene|August 30, 2001
No evidence of somatic FGFR3 mutation in various types of carcinomaM Karoui, H Hofmann-Radvanyi, U Zimmermann, et al.
British Journal of Cancer|March 18, 2004
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastasesM Karoui, C Tresallet, C Julie, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 29, 2009
Pharmacotherapy guidelines for the aged by family doctors for the use of family doctors - Part D Basic conditions supporting drug treatment. Part E Guidelines group, disclaimer, internet addressesGuidelines Group Hesse Pharmacotherapy Guidelines by Family Doctors for Family Doctors, F W Bergert, D Conrad, et al.
Journal of Materials Science. Materials in Medicine|June 2, 2005
Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantationH Zimmermann, D Zimmermann, R Reuss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trialL Bergmann, L Albiges, M Ahrens, et al.
Applied Biochemistry and Biotechnology|November 16, 2013
Patents and literatureM Kit, M J Narasimhan, J A Anderson, et al.
Pageof 39